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Abstract
Background: Effective and timely treatment is an essential aspect of malaria control, but remains
a challenge in many parts of sub-Saharan Africa. The objective of this study was to describe young
children's access to malaria treatment in Nouna Health District, Burkina Faso.
Methods: In February/March 2006, a survey was conducted in a representative sample of 1,052
households.
Results: Overall 149/1052 (14%) households reported the current possession of anti-malarial
medicine, which was significantly associated with urban area, literacy of household head, having
young children, and high socio-economic status. Out of a total of 802 children under five years, at
least one malaria episode was reported for 239 (30%) within the last month. Overall 95% of
children received treatment, either modern (72%), traditional (18%) or mixed (5%). Most of the
medicines were provided as home treatment by the caregiver and half of children received some
type of modern treatment within 24 hours of the occurrence of first symptoms. Despite a recent
policy change to artemisinin-based combination therapy, modern anti-malarials consisted mainly of
chloroquine (93%). Modern drugs were obtained more often from a health facility in localities with
a health facility compared to those without (60% vs. 25.6%, p < 0.001). In contrast, beside informal
providers, volunteer community health workers (CHW) were the main source of modern
medicine in localities without a health centre (28% vs. 3%, p < 0.001).
Conclusion: Access to modern health services providing quality controlled effective combination
therapies against malaria needs to be strengthened in rural Africa, which should include a re-
investigation of the role of CHW 30 years after Alma Ata.
Background
After decades of severe neglect, malaria control and even
malaria eradication are now back to the global health
agenda [1-3]. The Roll Back Malaria (RBM) partnership,
which was initiated in 1998 by three UN agencies and the
World Bank, has been very successful in raising global
awareness and in multiplying existing funds [4,5]. One
challenge is now to further increase and sustain funding
over the next decades as outlined in the Global Malaria
Action Plan of the RBM partnership [5].
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These promising developments are already accompanied
by a number of malaria control success stories in endemic
areas [6-16]. However, most of these examples are from
islands, fringes of endemic areas, smaller countries with
significant external support, or from more developed
countries outside sub-Saharan Africa (SSA). Whether
progress can be expected to be comparable in the majority
of SSA countries under the existing scenario of prevailing
poverty, weak infrastructure and management capacity,
unreliable donor funding, underused health services, and
high malaria transmission intensity, remains doubtful
[17,18].
Uptake of the main malaria control interventions--insecti-
cide-treated bed nets (ITN) and artemisinin-based combi-
nation therapy (ACT)--is still low in SSA, with only one
quarter of preschool children and pregnant women hav-
ing been protected with ITN and only 3% of fever epi-
sodes having been treated with ACT in 2006, although
numbers continue to increase [19-21]. Moreover, translat-
ing national policy changes such as changes in first-line
therapy for malaria into practice remains a long and com-
plicated process [22-26]. As a consequence, chloroquine
and other ineffective mono-therapies have until very
recently remained the treatment of choice for the majority
of malaria cases in many SSA countries [21,27]. Most of
the roughly one million annual malaria deaths occur in
young children of rural areas [28-31], where a high pro-
portion of cases rely on home-treatment with often sub-
standard drugs from shops and markets [30,32-34]. In
such areas and beside various socio-cultural and socio-
economic factors influencing the pattern of health care-
seeking behaviour, access to functioning modern health
services and effective treatment regimens remains the
major challenge to effective malaria control [30,35-44].
Burkina Faso, where malaria is holoendemic and repre-
sents a leading cause of infant mortality, adopted ACT as
first-line treatment against malaria in 2005. However, the
actual implementation of this national policy change took
some time and ACT was only made available in govern-
mental health services by the end of 2007. Here, the pat-
tern of health care-seeking behaviour and access to
modern health services and malaria treatment was ana-
lysed in young children of a rural district in Burkina Faso
in 2006, before the change to ACT effectively took place.
Methods
Study area
The study was carried out in the Nouna Health District
corresponding to the administrative province of Kossi in
north-western Burkina Faso, a rural, multi-ethnic, dry-
savannah orchard area of approximately 300,000 inhabit-
ants.
Malaria is holoendemic in the area with peak transmis-
sion occurring typically between July and November dur-
ing and shortly after the rainy season [45]. The 304
villages in the district were served by 25 primary health
care facilities, including 24 health centres known locally
as "Centre de Santé et Protection Sociale" in villages and one
hospital located in the semi-rural town of Nouna, the dis-
trict capital (see map in additional file 1). At the time of
the study, the personnel of the health facilities charged
patients for both consultation and drugs.
Household sampling
The study was nested into a large cluster-randomized ITN
trial in the Nouna Health District [46]. During this trial, a
three-step sampling scheme was used to randomly select
households for the survey. Briefly, the localities (villages
and Nouna town) were first divided into 25 clusters corre-
sponding to the geographical coverage area of the 25 pri-
mary health care facilities. Second, for each cluster, the
locality with the health facility was included and an addi-
tional village was randomly selected. Finally, within each
village 20 households were selected at random. In Nouna
town, which includes approximately 7.5% of the district
population, the sampling was done in every of its seven
sectors and included 72 households (10 in sector one to
six and 12 in sector seven). In total, 1,052 households
from 50 different localities (49 villages plus Nouna town)
were randomly selected, with 500 (47.5%) of them being
located in a locality without a health facility.
The median population of villages without a health centre
was 654 (range: 211-2,035) and the median distance by
road to the nearest modern health facility was 7 km
(range: 2-19 km). The median population of villages with
a health centre was 1,783 (range: 878-7,322) and that of
Nouna town 21,034.
Household questionnaire survey
The questionnaire consisting of 20 mostly closed-ended
questions inquired about the presence and origin of med-
icines in the household and about the occurrence and
possible treatment of a malaria episode in a child under
five within the last month (see survey questionnaire in
additional file 2). Questions were asked about symptoms;
response of the caregiver; medicines used as first, second
and third treatment; the person deciding to administer
treatment; origin of medicines; time between onset of
symptoms and start of treatment; duration of treatment
and outcome of illness episode. Furthermore household
heads were asked to report medicines used against malaria
that were present in their household. Medicines were
defined as drugs taken internally and included both mod-
ern medicines and traditional treatments. Because of self-
reporting, the drugs mentioned included actual modern
anti-malarial medicines as well as other non-anti-malarialMalaria Journal 2009, 8:266 http://www.malariajournal.com/content/8/1/266
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drugs. Modern medicines were defined as drugs that are
commercially-traded based on one or more active ingredi-
ents. The interviewers requested to directly see the medi-
cines and wrote down their name or described them as
precisely as possible if not identifiable by name (e.g.
round white tablets). Home treatment was defined as
medicines administered at home by the caregiver as
opposed to treatment recommended by individuals con-
sulted outside of the home such as medical professionals
or community health workers. For questions regarding
malaria episodes in children under five, the mother or
direct caregiver of the child was interviewed. The recall
period was one month. The terms used for malaria were
the French word "paludisme" and local word "soumaya"
describing a malaria episode [47].
The questions were initially formulated in French. After a
review with Burkinabé colleagues of the Nouna Health
Research Centre (CRSN) and a pilot test, the interviewers,
who spoke French, the local lingua franca Dioula and
some local languages, were trained to administer the
questionnaire so that the interview could be done in an
appropriate language for each household. Interviews were
carried out in the middle of the dry season (February/
March) 2006.
The socio-economic status of the household was esti-
mated by inventorying selected assets and computing
their combined value by multiplying their number by
their average market price. These assets included both
farm animals (poultry, sheep, goats, cows, donkeys, etc)
and other goods (radio, television, telephone, stove,
refrigerator, vehicles, and plough).
Quality control, data management and analysis
Every questionnaire was checked for completeness and
consistency by field supervisors. Data from the paper
questionnaires were entered by trained data entry clerks
into Microsoft Access 11.0 through a data entry mask with
a number of logical checks. At least one of the investiga-
tors was always present to answer questions, re-check ran-
domly questionnaires and data entry for error and ensure
overall quality control. Data analysis was done using
Microsoft Excel, SPSS 12.0 (SPSS Inc, Chicago IL, USA)
and SAS 9.2 (SAS Institute Inc., Cary, NC, USA). Measure
of association was determined by using the chi square test
in a univariate analysis and statistical significance was
declared for p < 0.05.
Ethical aspects
Ethical clearance was obtained from the ethic committee
of the University of Heidelberg and the local ethic com-
mittee of the CRSN. Explicit oral consent to participate
was obtained from the household head before each inter-
view by asking if he agreed that the household took part
in the study and stating that the interview could be
stopped at any time and without any negative conse-
quences.
Results
Demographic and socio-economic characteristics
The main ethnic groups represented in the survey were
Bwaba (42%; 439/1052), Marka (29%; 302/1052), Peuhl
(10%; 102/1052), Mossi (9%; 91/1052) and Samo (5%;
49/1052). Main religious groups were Muslims (50%;
527/1052) and Christians (37%; 385/1052). The majority
of households (87%; 912/1052) were headed by a farmer,
who was in most instances a man (95%, 1002/1052). The
literacy rate (defined as the self-reported ability to read
and write) among the male and female heads of house-
hold was 34% (340/1002) and 2% (1/50) respectively.
Availability of medicine in the household
Overall 14% (149/1052) of households reported the cur-
rent possession of anti-malarial medicine: 40% of these
(59/149) had modern anti-malarials, 48% (71/149)
modern anti-pyretics, 13% (19/149) other modern drugs,
and 36% (53/149) traditional medicine. Antipyretics con-
sisted of paracetamol (93%, 66/71) and aspirin (7%, 5/
71) while modern anti-malarials consisted of chloroquine
(86%, 51/59), quinine (7%, 4/59), amodiaquine (5%, 3/
59), and sulphadoxine-pyrimethamine (SP) (2%, 1/59).
Thus, less than 1% (8/1052) of all households had a stock
of somewhat effective anti-malarials (quinine, amodi-
aquine, SP). Other modern drugs included antibiotics,
anti-helmintics and anti-tussive drugs.
Origin of modern medicine in the household
The origin of modern drugs found in households was var-
ied and included official sources, such as pharmacies in
health facilities and private pharmacies as well as the illicit
market, namely shops or street/market vendors. Most
modern drugs were obtained from a health facility (65%,
96/147) while in 23% (34/147) of households, they were
obtained from the illicit market or from unknown
sources. Amodiaquine, SP and quinine were only availa-
ble in households located in villages with a health centre
and had all been obtained either from health facilities or
private pharmacies. In contrast chloroquine and anti-
pyretics were available in all villages but still originated
predominantly from official sources (80%, 41/51 and
72%, 51/71, respectively). Modern drugs in households
were found more frequently in localities with a health
facility compared to localities without (17%, 91/552 vs.
11%, 56/500, p = 0.01). Furthermore, modern drugs were
purchased more frequently from a health facility in local-
ities with a health facility compared to localities without
(75%, 68/91 vs. 50%, 28/56, p = 0.004). 80% (12/15) of
modern drugs purchased through the illicit market came
from households in villages without a health centre andMalaria Journal 2009, 8:266 http://www.malariajournal.com/content/8/1/266
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only in these villages were modern drugs (7%, 4/56)
obtained from volunteer community health workers
(CHW).
Factors influencing the availability of modern medicine in 
the household
Table 1 shows how different household factors influenced
the likelihood of having modern medicine in the house-
hold. Households located within 5 km of a health facility
were slightly more likely to have modern medicine avail-
able at home compared to those located farther than 5 km
away (11% vs. 7%, p = 0.07). A statistically significant dif-
ference was observed for households located in urban as
compared to rural areas (18% vs. 9%, p = 0.01)
Other factors increasing the likelihood of medicine being
present in the household included household head being
literate (14% vs. 7%, p < 0.001), having at least one child
under five (14% vs. 8%, p = 0.006), and increasing eco-
nomic assets (16% vs. 4%, p < 0.001, when comparing the
highest and lowest quartiles).
Malaria episodes in young children
Out of the 1052 households surveyed, 76% (802/1052)
had children under the age of five years (Figure 1). Of
these households, 30% (239/802) reported at least one
malaria episode in a young child within the last month.
There were no differences in the number of self-reported
malaria episodes between villages with or without a
health centre. While 95% (227/239) of episodes were
treated with modern, traditional or mixed medicine, 5%
(12/239) of episodes were not treated with medicine
taken internally. Treatment consisted either of modern
medicine in 72% (172/239), traditional remedies in 18%
(44/239) or a mix of both in 5% (11/239) of cases.
Reported malaria symptoms included fever (90%, 216/
239), vomiting (46%, 109/239), lack of appetite (21%
50/239), shivering (7%, 16/239) and convulsions (3%, 8/
239). Coughing (26%, 62/239) and diarrhoea (24%, 58/
239) were also frequently reported.
First action of caregivers and treatment of malaria 
episodes
Figure 2 shows the first action taken by parents/caregivers
with the occurrence of symptoms in under five children.
Home treatment by the caregiver was the most frequent
procedure, followed by treatment through a medical pro-
fessional (nurse or medical doctor). Home treatment was
not statistically different in localities with compared to
localities without a health facility (41% vs. 46%, p =
0.435). In localities with a health facility compared to
localities without one about twice as many children were
taken to a medical professional first (27% vs. 13%, p =
0.005). Visiting a CHW or a traditional healer immedi-
ately was only reported in a very small number of cases.
Table 1: Factors influencing the likelihood of presence of modern medicine in the household. 
Factors Total N % OR 95% CI
Health facility in locality
No 500 40 8.0% 1
Health centre (in village) 480 48 10.0% 1.28 0.82-1.98
District hospital (in Nouna) 72 13 18.1% 2.53 1.28-5.01
Urban vs. Rural
Rural 980 88 9.0% 1
Urban 72 13 18.0% 2.23 1.18-4.23
Distance from health facility
0-5 km 672 73 10.9% 1
>5 km 380 28 7.4% 0.65 0.41-1.03
Age of child
No child under five yr 813 67 8.2% 1
0-11 months 45 9 20.0% 2.79 1.29-6.03
12-60 months 194 25 12.9% 1.65 1.01-2.69
Household head literate
No 711 52 7.3% 1
Yes 341 49 14.4% 2.13 1.41-3.22
Asset-based indicator
1st quartile (poorest) 263 11 4.2% 1
2nd quartile 264 19 7.2% 1.78 0.83-3.81
3rd quartile 262 30 11.4% 2.96 1.45-6.04
4th quartile (richest) 263 41 15.6% 4.23 2.12-8.43
'Total' indicates the number of households for each factor categories; 'N' is the number of households where modern medicine was present and '%' 
the corresponding percentage of households.; The odds ratio (OD) with the corresponding 95% confidence interval (95% CI) are given. Statistically 
significant results are in boldMalaria Journal 2009, 8:266 http://www.malariajournal.com/content/8/1/266
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77% (183/239) of children with reported malaria
received some type of modern medications as first treat-
ment (Figure 1). Administration of multiple modern
medication was frequently observed and included chloro-
quine (45%, 108/239), amodiaquine (2%, 5/239), qui-
nine (1%, 2/239), SP (0.4%, 1/239), anti-pyretics (54%,
130/239), antibiotics (6%, 14/239), and unspecified or
other drugs (18%, 43/239). 38% (91/239) of children
received a combination of anti-malarial and anti-pyretic.
Chloroquine represented 93% (108/116) of all anti-
malarials administered. No child received an artemisinin
drug or ACT. 14% (33/239) of children received a treat-
ment with modern drugs that could not be remembered
or named by the caregiver and might have been an anti-
malarial.
Overall, 61% (146/239) of children received some type of
medicine within 24 hours of first symptoms; this figure
increased to 81% (193/239) when considering the first 48
hours (Figure 3). Of children being treated during the first
24 hours, 33% (78/239) received modern anti-malarials.
In case of home treatment, 58% (60/104) of children took
modern anti-malarials within 24 hours. Literacy of the
head of the household was the only factor that increased
the likelihood that the child be treated within 24 hours
(71% vs. 56%, p = 0.02). Other factors such as presence of
a health facility in the locality, distance of household to a
health facility, age of the child, sex of household's head,
ethnic group, or socio-economic status were not associ-
ated with early treatment.
Origin of the medicine used for malaria treatment in young 
children
The decision to buy/use a certain modern treatment was
taken by the parents in 61% (112/183) and by a medical
doctor, nurse, or pharmacist in 33% (60/183) of the ill-
ness episodes. Modern medicine used for first treatment
was bought more often from a health facility in localities
with a health centre compared to those without (60% vs.
25.6%, p < 0.001) (Figure 4). In contrast, CHW were the
main source of modern drugs in localities without a
health facility (26% vs. 3%, p < 0.001). A trend indicated
that drugs were bought more often at illicit markets (street
vendors, markets, shops) in localities without than in
localities with a health facility (20% vs. 11%, p = 0.07).
Fifteen percent (33/227) of the drugs used for first treat-
ment were already available in the household at the time
Treatment of malaria episodes in children under five Figure 1
Treatment of malaria episodes in children under five.
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of the child's malaria episode and of those 79% (26/33)
were modern drugs.
Second/third treatment and outcome of malaria episodes
Twenty-five children (11%, 25/239) received a second
treatment and of these six (3%, 3/239) took a third treat-
ment. No child that had been treated with amodiaquine,
SP or quinine as first treatment received a second treat-
ment. However, among the children that received a sec-
ond treatment, 16 were treated with modern medicine
including three taking amodiaquine or SP, and five taking
chloroquine. No anti-malarials were given as third treat-
ment.
At survey time the illness was still on-going for 18% (42/
239) of the study children, while the majority (82%, 196/
239) had recovered. Overall 4% (9/239) of children were
hospitalized (seven in a health centre and two in the
Nouna district hospital); one child (0.4%) died at the
Nouna hospital.
Discussion
This study provides detailed information on access to and
use of anti-malarial drugs from an African area with high
malaria transmission intensity. The data from this large
household survey are representative for a rural health dis-
trict of Burkina Faso and can probably be considered com-
parable to the situation in many rural areas of West Africa.
The data were collected in 2006, when ACT had already
become first-line treatment for malaria in most of the
malaria endemic countries of SSA including Burkina Faso
[5,21,27].
Not much information exists on the availability of anti-
malarial medicine in households of the endemic areas in
SSA. In Tanzania home stocking of anti-malarials in
households ranged from 33% at the time of chloroquine
to 8% at the time of SP first-line treatment [48]. In the
Nouna area it was shown that 14% of households pos-
sessed medicines perceived to be effective against malaria,
Time between the occurrence of first symptoms and start of  treatment (N = 239) Figure 3
Time between the occurrence of first symptoms and 
start of treatment (N = 239).
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and the availability of more effective anti-malarials was
slightly (p = 0.07) associated with the proximity of a
health facility. Such households have better access to
medicines and may benefit in case of disease. Important
determinants of anti-malarial medicine in households
identified in this study were the availability of modern
health facilities in the community as well as household
characteristics, such as literacy of household head, pres-
ence of young children, and high socio-economic status.
However, how to interpret better availability of modern
drugs in households is not clear. The possession of drugs
could be beneficial as malaria might be treated earlier, but
could also become problematic if this leads to non-adher-
ence with official drug regimens. Thus, further studies on
this topic are needed after ACT as first-line treatment -
with or without laboratory-based diagnosis - has become
fully implemented in the area.
Among the main findings from this study is that the great
majority of malaria episodes were still treated with chlo-
roquine, anti-pyretics and traditional medicine, which
confirms former findings [27,49] and fits well with the
pattern of household availability of anti-malarials found
in this study. More effective modern anti-malarials such as
amodiaquine, SP or quinine were only used in a small
proportion of cases and exclusively in localities with mod-
ern health facilities. ACT, despite being the official first-
line regimen for malaria treatment since 2005, was not
used at all. These findings confirm the still very low ACT
coverage in SSA and provide further evidence for the diffi-
culties related to treatment policy changes in malaria
endemic countries [21,24,50,51].
Another important finding is that most of the modern
anti-malarials originated from governmental health serv-
ices, with health centres being the main source for pur-
chase of drugs in localities with a health centre and CHW
being the main source for purchase of drugs --but interest-
ingly not as point of first reference after the start of symp-
toms-- in localities without a health centre. In Burkina
Faso, CHW were trained and established in villages with-
out a health centre during the 1980s, but have not
received much attention or specific support thereafter. In
recent years, a number of community-based projects as
well as the Ministry of Health have trained or re-trained a
certain number of CHW in many villages of Burkina Faso.
However, no official document is available on the current
status and function of the remaining CHWs in the villages
of the Nouna Health District. As there is currently an inter-
national revival of the primary health care (PHC) move-
ment [52-56], strengthening the role of CHW in malaria
treatment and beyond should be considered as a potential
answer to the lack of access to modern health services and
the health worker crisis in SSA [15,57-61]. Some promis-
ing examples from Asia and Africa regarding the role of
CHWs in improving access to ACT have recently been
published [62,63]. Apart from being equipped with effec-
tive oral anti-malarial regimens, such volunteers may also
use pre-referral rectal artesunate in children with severe
malaria to reduce mortality [64]. However, such pro-
grammes would need to be accompanied by political sup-
port from the highest levels as well as by measures to
improve the training, motivation and supervision of
CHW [9,65-67].
Another finding of this study was that modern anti-malar-
ials were more often purchased from illicit sources, such
as shops and markets, in communities without a health
centre compared to those with a health centre. In a recent
study conducted in the same study area, it was shown that
many of the anti-malarials purchased from illicit sources
were of substandard quality [34]. This further supports the
importance of access to functioning health services
including quality-controlled drugs in rural SSA [50,68-
70]. Highly subsidized and quality-controlled ACT regi-
mens supported by a global funding mechanism could be
one answer to the problem [71,72].
Early access to effective treatment is clearly associated with
reduced malaria morbidity and mortality in endemic
areas [29,73]. In this study, it was reported that roughly a
third of all under five children received treatment with
some type of modern anti-malarial drug within 24 hours
of the onset of symptoms, and this figure increased to
58% when considering only home treatment. The Abuja
declaration stated that at least 60% of malaria cases
should have prompt access to affordable and appropriate
treatment within 24 hours of the onset of symptoms [74]
while more recent targets of the RBM partnership have
called for at least 85% of malaria cases in children under
five having received ACT treatment within 24 hours of the
onset of symptoms [75]. However, even without consider-
ing the high resistance of Plasmodium falciparum against
chloroquine and the non-availability of ACT at the time of
the study in the Nouna area [27], these targets have not
been reached. This supports similar findings from other
SSA areas [36,76-78]. Interestingly, in the Nouna area
home treatment with modern anti-malarials was started
much more rapidly compared to treatment given by a
medical professional. This highlights again the impor-
tance of access to modern medicine and points to the
likely benefit of reviving the CHW concept in rural SSA
[9,66]. Home treatment services using CHW or alternative
volunteers such as mother group leaders in collaboration
with the nurses of existing health facilities were recently
shown to be feasible and effective in increasing treatment
coverage in SSA countries including Burkina Faso
[9,51,63,79,80].Malaria Journal 2009, 8:266 http://www.malariajournal.com/content/8/1/266
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The finding of this study that subsequent treatments were
applied only in cases where chloroquine and not of other
modern anti-malarials were used as first treatment sup-
ports evidences of the high level of chloroquine resistance
in the area [27]. Out of 239 reported febrile disease epi-
sodes resembling malaria, nine cases were hospitalized
and one child died. As the proportion of true malaria
cases amongst these episodes is unknown, it is not possi-
ble to estimate cause-specific mortality rates from these
figures.
Due to new funding through the Global Fund against
AIDS, tuberculosis and malaria, ACT is now available in
the Nouna Health District as in all of Burkina Faso since
the end of 2007. These drug regimens can be purchased
from all governmental health facilities at a subsidized
prize, which is however several times above the former
prize for chloroquine. Moreover, long distances to rural
health centres, transport problems and lack of money to
pay for transport, services and opportunity costs will cer-
tainly continue to limit early access of young children
with malaria to modern health facilities in Burkina Faso,
as in most of rural SSA [21,27,30,41,81,82]. Strengthen-
ing the role of CHW or other volunteers trained to distrib-
ute anti-malarials may thus remain the only short-term
solution for increasing access to early effective malaria
treatment in rural SSA.
This study has some limitations. Firstly, having been part
of a repeated annual cross-sectional household survey in
the Nouna Health District in the frame of an ITN trial
[46], the study was conducted in the middle of the dry sea-
son. Thus, compared to the situation during the rainy sea-
son a higher proportion of the reported malaria cases may
in fact be fever cases of other origin. However, the rural
Nouna study area is holoendemic for malaria [45] and
even during the dry season high levels are observed in
term of Plasmodium falciparum parasites in peripheral
blood with 60 to 80% of under-five children being posi-
tive by routine blood smear tests and in term of falci-
parum malaria prevalence, defined as a fever episode plus
a blood parasite count greater than 2,000 per microliter
and which ranges between 2 to 5% among under-five chil-
dren (Mueller, unpublished results). Secondly, due to the
study design the study populations may not be totally rep-
resentative for the whole district. Not all participating vil-
lages were selected at random and those with a health
centre were usually larger than those without a health cen-
tre. This could have introduced a bias as the localities with
a health facility may differ from those without a health
facility in a number of only partly measured socio-demo-
graphic and socio-economic parameters. Finally, the find-
ings reported from this study are based on self-reported
information on morbidity, health care-seeking behaviour,
and drug ownership and use. Such data may be influenced
by reporting bias due to imprecise remembering of events,
lack of knowledge on specific medicines, or perceived
pressure to provide socially acceptable answers.
Conclusion
In conclusion, access to modern quality health services
and effective anti-malarials remains severely limited in
rural Burkina Faso as in most of SSA. Given the continu-
ous financial and health worker crisis, innovative systems
of home treatment based on locally appropriate primary
health care strategies such as revival of CHW strategies or
training and support of other community volunteers,
which needs to include the large-scale provision of effec-
tive anti-malarial regimens, such as ACT, should be
piloted more vigorously in the malaria endemic rural
areas of SSA. Such pilot schemes need of course to be
accompanied by well-designed applied research. Thirty
years after Alma Ata, it is urgent time to roll out compre-
hensive primary health care in SSA.
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